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for mortality in elderly patients with sepsis:
a retrospective cohort study
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Abstract
Background: Older patients account for the majority of patients with sepsis. The objective of this study was to
determine if decreased skeletal muscle mass is associated with outcomes in elderly patients with sepsis.
Methods: Patients (60 years and older) who were admitted to a tertiary medical center intensive care unit with a
primary diagnosis of sepsis between January 2012 and February 2016 were included. Patients who had not
undergone abdominal computed tomography on the day of admission, had cardiopulmonary arrest on arrival, or
had iliopsoas abscess were excluded from the analyses. Cross-sectional muscle area at the 3rd lumber vertebra was
quantified, and the relation to in-hospital mortality was analyzed. Multivariable logistic regression analysis that
included sex and APACHE II score as explanatory variables was performed. The optimal cutoff value to define
decreased muscle mass (sarcopenia) was calculated using receiver operating characteristic curve analysis, and the
odds ratio for in-hospital mortality was determined.
Results: There were 150 elderly patients with sepsis (median age, 75 years) enrolled; in-hospital mortality and
median APACHE II score were 38.7 and 24%, respectively. The skeletal muscle area of deceased patients was
significantly lower than that of the survival group (P < 0.001). The multivariable logistic regression analysis
demonstrated that decreased muscle mass was significantly associated with increased mortality (odds ratio = 0.94,
95% confidence interval = 0.90 to 0.97, P < 0.001). The optimal cutoff value of skeletal muscle area to predict in-
hospital mortality was 45.2 cm2 for men and 39.0 cm2 for women. With these cutoff values, the adjusted odds ratio
for decreased muscle area was 3.27 (95% CI, 1.61 to 6.63, P = 0.001).
Conclusions: Less skeletal muscle mass is associated with higher in-hospital mortality in elderly patients with sepsis.
The results of this study suggest that identifying patients with low muscularity contributes to better stratification in
this population.
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Background
Sepsis is a clinical syndrome characterized by physio-
logic, biologic, and biochemical abnormalities caused by
a dysregulated inflammatory response to infection. It
also includes organ dysfunction attributed to it and is a
major public health concern. The reported incidence is
disproportionately higher in older patients. Older pa-
tients account for the majority (60–85%) of all episodes,
and this figure is likely to increase in the future [1–3].
Therefore, the importance of accurate stratification of
elderly patients with sepsis is growing, as it can aid in
developing a treatment strategy, allocating healthcare re-
sources, and assessing the effectiveness of novel therap-
ies. While chronologic age is an important element in
assessing the anomaly in the host’s inflammatory re-
sponse, physiologic age is a more important determinant
of outcomes. Recently, sarcopenia, which is defined as
the loss of skeletal muscle mass and strength with ad-
vancing age [4], has increasingly been recognized as an
important factor that can act as a marker of decreased
physiologic reserve because it is highly important for
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immune function, glucose disposal, protein synthesis,
and mobility [5, 6].
We hypothesized that decreased skeletal muscle mass
is a predictive marker for the outcome of elderly patients
with sepsis. In this retrospective study, we investigated
whether decreased skeletal muscle mass is associated
with in-hospital mortality in elderly patients with sepsis.
Methods
Population cohort and data acquisition
Patients who were admitted to a tertiary medical center
intensive care unit (ICU) with a primary diagnosis of sep-
sis between January 2012 and February 2016 were retro-
spectively identified. Our tertiary medical center admits
only severe patients either directly transferred from the
scene by an emergency response team or referred from
another medical facility. We employ a strategy, wherein,
we aggressively perform torso CT on almost all patients.
This entails confirmation of the potential source of infec-
tion, assessment of anatomical structures of the lesion in
detail, and identification of any coexisting lesions as reli-
ably and immediately as possible. Elderly (60 years and
older) patients were included in the analysis. Patients were
excluded from the analysis who had not undergone ab-
dominal computed tomography (CT) on the day of admis-
sion or had cardiopulmonary arrest on arrival (CPAOA).
Because updated definitions of sepsis that offer greater
consistency for clinical trials were released in 2016 [7], we
determined whether the patients met the revised criteria
for sepsis; otherwise, they were excluded from the study.
Patients with iliopsoas abscess were also excluded from
the analysis because of the possible confounding effect on
skeletal muscle area.
Demographic and clinical data included age, sex, body
weight, Glasgow coma scale (GCS) score, body
temperature, mean arterial pressure, heart rate, respiratory
rate, arterial oxygen partial pressure, fractional inspired
oxygen, blood test results (platelets, bilirubin, creatinine,
Na, K, hematocrit, white blood cell count, and lactate on
admission), administration of vasopressors, length of stay
(LOS) in the hospital, LOS in the ICU, in-hospital mortal-
ity, location of death, infection source, chronic health prob-
lems, and recent surgery. We calculated the Sepsis-related
Organ Failure Assessment (SOFA) score [8], which deter-
mines the extent of a patient’s organ failure based on the
respiratory, cardiovascular, hepatic, coagulation, renal, and
neurological systems, as well as the second version of the
Acute Physiology and Chronic Health Evaluation (APACHE
II) score [9], which determines the severity of disease based
on a patient’s age and physiological measurements.
Computed tomography measurement
Access to computed tomography (CT) images on the day
of admission was available through the picture archiving
and communication system (PACS; SYNAPSE software,
Fujifilm Medical Co., Tokyo, Japan). After the observer
outlined the muscle, the range of the area of interest was
calculated by the software. Muscle attenuation, a measure
of muscle density and fatty infiltration, was quantified
using Hounsfield units (HU) obtained from the CT image.
Lean skeletal muscle mass was estimated by measuring
the cross-sectional area of the psoas and paraspinal (quad-
ratus lumborum, erector spinae) muscles at the third lum-
ber vertebra (L3) as shown in Fig. 1. A strong correlation
between the cross-sectional area of skeletal muscle at this
landmark and whole-body muscle distribution has been
reported, and the validity and reliability of this method to
estimate lean skeletal muscle mass have been established
[10–12]. HUs within the range of interest of each muscle
were calculated, and the average value was used for the
final muscle attenuation. The observer was blinded to
patients’ survival status.
Statistical analysis
Patients were grouped according to outcome (survival or
deceased). For descriptive statistics, numeric or ordered
variables are presented as medians with interquartile
ranges and were compared using Mann–Whitney U
tests. Categorical variables are presented as counts and
percentages and were tested for significance using Fish-
er’s exact tests. We used a multivariable logistic regres-
sion model to determine whether decreased skeletal
muscle area is independently associated with in-hospital
mortality in patients with sepsis. We also performed
additional stratified analyses that divide patients into
two groups of 60–80 years and over 80 years to adjust
heterogeneity because muscle mass of over 80 years is
lost at an accelerated rate (15%/year) compared to the
rate of approximately 8% per decade from the age of
50 years [13]. To minimize the risk of falsely identifying
Fig. 1 CT image at the L3-sectional muscle. The right L3-sectional
muscle area is outlined. Muscle area and mean muscle attenuation
are calculated by the picture archiving and communication system
(PACS) software
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significant results, explanatory variables were prede-
termined before the analysis based on previous studies [9,
14–16]. In addition to the skeletal muscle area, the APA-
CHE II score and sex were included in the model. To test
multicollinearity, we evaluated the variance inflation fac-
tor. To determine the optimal cutoff value of skeletal
muscle area for predicting in-hospital mortality and the
area under the curve (AUC), we performed receiver oper-
ating characteristic (ROC) curve analysis. We defined the
patients with a skeletal muscle area lower than the cutoff
value as sarcopenic, and the odds ratio for mortality was
determined. For each groups, event-time distributions
were estimated with the use of the Kaplan–Meier method.
The difference of estimated survival rate was tested using
log-rank test. We performed an analysis using Cox
proportional hazards regression and taking time to in-
hospital death as the dependent variable and sarcope-
nia as the main predictor variable. To adjust for po-
tential confounders, APACHE II score and sex were
included in a multivariable model. Hazard ratios and
95% confidence interval (CI) are given. All statistical
tests were two-tailed, and P values <0.05 were consid-
ered significant.
All statistical analyses were performed with EZR
(Saitama Medical Center, Jichi Medical University,
Saitama, Japan), which is a graphical user interface for R
(The R Foundation for Statistical Computing, Vienna,
Austria). More precisely, it is a modified version of R
commander designed to add statistical functions fre-
quently used in biostatistics [17].
Table 1 Patient characteristics and radiological findings
All patients Group P value
Survival Deceased
Number of patients 150 92 58
Location of death
ICU 44
After transferred to general floor 14
Age (years) 75 [68, 82] 74 [67, 81] 77 [71, 83] 0.13
Sex, men (%) 103 (69) 63 (69) 40 (69) 0.99
GCS 14 [9, 15] 14 [10, 15] 12 [7, 15] 0.21
Lactate on admission (mmol/L) 4.2 [2.3, 7.2] 3.9 [1.8, 6.3] 5.9 [2.4, 8.9] 0.053
Infection source (%) 0.33
Lung 45 (30) 23 (25) 22 (38)
Urinary tract 32 (21) 24 (26) 8 (14)
Peritonitis/abscess 16 (11) 8 (9) 8 (14)
Perforated viscus 15 (10) 10 (11) 5 (9)
Cholecystitis/cholangitis 10 (7) 8 (9) 2 (3)
Unknown 9 (6) 4 (4) 5 (9)
NecFas/decubitus ulcer 8 (5) 5 (5) 3 (5)
Ischemic bowel 5 (3) 3 (3) 2 (3)
Colitis 5 (3) 4 (4) 1 (2)
Blood stream infection 3 (1) 1 (1) 2 (3)
Bone/joint 1 (1) 1 (1) 0 (0)
CNS 1 (1) 1 (1) 0 (0)
SOFA score 9 [7, 12] 8 [7, 11] 10 [8, 12] 0.004
APACHE II score 24 [19, 30] 23 [18, 27] 26 [22, 34] 0.002
Body weight (kg) 54 [48, 60] 54 [48, 61] 54 [48, 58] 0.42
Skeletal muscle area (cm2) 41.6 [34.0, 48.1] 43.3 [36.5, 50.9] 36.8 [30.1, 43.2] <0.001
Muscle attenuation (HU) 32.6 [24.1, 39.9] 33.2 [24.2, 40.0] 31.0 [23.6, 39.8] 0.38
LOS in ICU 8 [4, 15] 9 [6, 15] 5 [2, 14]
LOS in hospital 27 [7, 51] 40 [18, 62] 8 [3, 25]
ICU intensive care unit, GCS Glasgow coma scale, NecFas necrotizing fasciitis, CNS central nervous system, SOFA Sepsis-related Organ Failure Assessment, APACHE II
second version of the acute physiology and chronic health evaluation, HU Hounsfield unit, LOS length of stay
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Results
During the study period, 168 patients met the inclusion
criteria. Of those, patients were excluded for the follow-
ing reasons: n = 4, no abdominal CT; n = 10, CPAOA;
and n = 1, had an iliopsoas abscess. Of the remaining
153 patients, 3 patients who did not meet the recent cri-
teria for sepsis were excluded, resulting in 150 patients
(103 men, 47 women; age 75 [68, 82] years) in the ana-
lysis. All the predictors required to calculate the APA-
CHE II and SOFA scores were present in the dataset.
The clinical characteristics and radiological features
are summarized in Table 1. The overall APACHE II
score was 24 [18, 19], and the in-hospital mortality rate
was 38.7%. Lactate level on admission was 4.2 [2.3, 7.2],
and that of 116 patients (77%) were higher than
2.0 mmol/L. The survival group included 92 patients,
and the deceased group included 58 patients. Of the 58
deceased patients, 44 deceased at ICU and 14 deceased
after transfer to general floor. The APACHE II score was
significantly higher in the deceased group (P = 0.002).
The median skeletal muscle area in all patients was
41.6 [34.0, 48.1] cm2. Those of the survival group was
significantly larger than the deceased group (43.3 [36.5,
50.9] and 36.8 [30.1, 43.2] cm2, P < 0.001; Fig. 2). The
SOFA score of the deceased group was significantly
higher than that of the survival group (P = 0.004).
The results of the multivariable regression analysis are
shown in Table 2. The variance inflation factors for multi-
collinearity were lower than 1.06 among the predeter-
mined explanatory variables. Among the variables, skeletal
muscle area (cm2) was an independent predictive param-
eter for in-hospital mortality, and the adjusted odds ratio
was 0.94 (95% CI, 0.90 to 0.97, P < 0.001). In the stratified
analysis, the association between skeletal muscle area and
in-hospital mortality was significant in both groups of
60–80 years and over 80 years, and the adjusted odds
ratio was 0.96 (95% CI, 0.92 to 0.99, P = 0.032) and 0.89
(95% CI, 0.81 to 0.98, P = 0.016), respectively.
The cutoff value of skeletal muscle area to predict in-
hospital mortality was calculated for each sex because
the skeletal muscle area was significantly larger in men
than in women (43.1 [35.5, 51.0] vs 39.0 [33.1, 43.0] cm2,
P = 0.005; Fig. 3). ROC curve analysis demonstrated that
the optimal cutoff values were 45.2 cm2 for men and
39.0 cm2 for women, and the AUCs were 0.65 (95% CI,
0.54 to 0.76) and 0.72 (95% CI, 0.58 to 0.88), respect-
ively. Based on our definition of sarcopenia (using the
cutoff value), in-hospital mortality was significantly
higher for patients with sarcopenia, and the adjusted
odds ratio was 3.27 (95% CI, 1.61 to 6.63, P = 0.001).
Kaplan–Meier estimates of mortality were drown for
each group (Fig. 4). The estimated survival rate 100 days
after admission was 0.70 (95% CI, 0.54 to 0.81) for not
sarcopenic patients and 0.37 (95% CI, 0.23 to 0.50) for
sarcopenic patients, and the difference was significant
(P < 0.001). Cox proportional hazards regression analysis
showed a higher risk of in-hospital mortality for sarcope-
nic patients even when adjusted for APACHE II score
and sex, and the hazard ratio was 2.55 (95% CI, 1.43 to
4.56, P = 0.001).
Discussion
Sarcopenia is important as an independent predictor of
falls, disability, loss of independence, and increased mor-
tality. While the prognostic value of sarcopenia has been
determined for patients after surgery, trauma, or with can-
cer [9–12, 18, 20–25], its importance for patients with
sepsis has not been evaluated. In the present sample of
elderly patients with sepsis admitted to a tertiary medical
Fig. 2 Comparison of the skeletal muscle area between survival
group and deceased group. Skeletal muscle area was significantly
larger in survival group (43.3 [36.5, 50.9] vs 36.8 [30.1, 43.2], P < 0.001)
Table 2 Results of multivariable logistic regression analysis to
determine variables independently associated with in-hospital





Skeletal muscle area (cm2) 0.94 (0.90–0.97) <0.001
APACHE II score 1.07 (1.02–1.12) 0.003
Sex, men 1.46 (0.67–3.22) 0.34
Stratified analysis
60–80 years
Skeletal muscle area (cm2) 0.96 (0.92–0.99) 0.032
Over 80 years
Skeletal muscle area (cm2) 0.89 (0.81–0.98) 0.016
APACHE II second version of the Acute Physiology and Chronic
Health Evaluation
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center ICU, decreased skeletal muscle mass was a signifi-
cant predictor of in-hospital mortality. This is the first
study, to the best of our knowledge, to examine the impli-
cations of sarcopenia in elderly patients with sepsis.
A wide range of techniques can be used to assess
muscle mass. CT and magnetic resonance imaging
(MRI) are considered to be very precise imaging systems
and as gold standards for estimating muscle mass. In
this study, we used the cross-sectional area of the
muscle determined using CT; this provides an estima-
tion of the overall muscle mass and has been used in a
variety of studies to predict lean muscle mass [10–12].
While it is difficult to perform these measurements for
the sole purpose of estimating skeletal muscle mass, CT
is frequently required in patients with sepsis as a part of
the initial work up; therefore, an early assessment of
muscularity in this patient population is possible, and
the cross-sectional view of the muscle provides an easily
obtained objective method for estimating lean muscle
mass in these patients. Because it takes only a few mi-
nutes, it can be easily performed in most clinical scenar-
ios. A strength of this study is the ease of incorporating
our findings into practice.
Clinical characteristics that impact the severity of sepsis
and outcome include the host’s response to infection, site
and type of infection, and therapeutic strategy. The thera-
peutic strategy for sepsis has been standardized in practice
guidelines; several studies have reported decreasing
sepsis-related mortality rates over time with the imple-
mentation of therapeutic strategies, after adjusting for
multiple variables, suggesting improvement owing not
only to sepsis criteria and to the progress in medicine in
general but also to these strategies [26, 27]. Furthermore,
the importance of the host response as a prognostic factor
for patients with sepsis is growing. Among the factors re-
lated with host response, age is reportedly a primary risk
factor for mortality because of its association with comor-
bid illnesses, impaired immunologic responses, malnutri-
tion, and increased exposure to potentially resistant
pathogens. Although chronologic age is a good objective
marker of the anomaly in the host response and included
in scoring models of prognosis for patients in the ICU,
considerable individual variation in physical condition ex-
ists among the elderly. While muscle mass is generally lost
with aging and the prevalence of sarcopenia ranges be-
tween 5 and 13% in older people, the severity of muscle
loss significantly varies in this population. In the current
Fig. 3 Comparison of the skeletal muscle area between men and
women. Skeletal muscle area was significantly larger in men
(43.1 [35.5, 51.0] vs 39.0 [33.1, 43.0], P = 0.005)
Fig. 4 Kaplan–Meier estimates of time to death. Estimated survival rate at 100 days after admission was significantly different between two
groups (log-rank test P = 0.001). Risk of in-hospital mortality was significantly higher for sarcopenic patients even when adjusted for APACHE II
and sex (Cox proportional hazards regression analysis, hazard ratio 2.55, P = 0.001)
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study, we confirmed associations between decreasing
muscle mass and sepsis related mortality. Because skeletal
muscle atrophy can cause physical decline such as im-
paired cytokine [28] and insulin signaling [19, 29] that
may result in glucose intolerance, we speculate that
stratification by muscle mass may reflect physical age
and help circumvent the difficulties associated with
prognostication and classification of elderly patients
with sepsis by chronologic age. The mechanisms for the
relationship between sarcopenia and poor prognosis
cannot be definitively determined because of the study
design. However, the results of the current study high-
light the need to prevent progressive loss of skeletal
muscle mass and function in the elderly.
The literature suggests that the combination of exer-
cise and nutrition is the key intervention for preventing,
treating, and slowing down the progress of sarcopenia
[30, 31]. Resistance exercise combined with protein sup-
plementation at higher protein doses of 40 g leads to
greater muscle gain than exercise or protein supplemen-
tation alone in the elderly [31, 32]. The awareness of the
benefits of exercise and diet is not enough in older
people. Enhancing participation in exercise for older
patients might prevent sarcopenia and improve sepsis
outcomes in the elderly population. Rehabilitation and
nutritional strategies that focus on preventing muscle
loss may also contribute to better outcomes. Further re-
search is required to test these hypotheses; however, the
results of the present study highlight the importance of
muscle mass in patients with sepsis.
Limitations
Owing to the retrospective design, biases and confounding
are major concern. We tried to adjust for possible con-
founders such as age, comorbidity, recent surgery, and sex
by performing multivariable regression analysis using the
APACHE II score, which is calculated with these variables,
and sex as explanatory variables. This study was per-
formed at a single center with a small sample. Because it
is our strategy to aggressively perform torso CT for pa-
tients with sepsis, almost all patients including those with
lung infection, CNS infection, and necrotizing fasciitis/de-
cubitus ulcer undergo abdominal CT at our ICU. Some in-
stitutes may not perform abdominal CT for such cases.
Hence, the infection source of patients with abdominal
CT may differ between other studies and the present
study, limiting external validity of our results. We expect
similar associations between muscle mass and in-hospital
mortality in other cohorts; however, the optimal cutoff
value should be validated. We report that the odds ratio
for in-hospital mortality was 3.27, but the 95% CI was
wide, with a minimum value of 1.61. Further research with
a larger sample is necessary to establish the clinical signifi-
cance of sarcopenia.
Conclusions
We found that less skeletal muscle mass is associated
with higher in-hospital mortality of elderly patients with
sepsis. The results of this study suggest that identifying
patients with low muscularity may contribute to better
stratification of elderly patients.
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